FUTURA MEDICAL PLC

• ⚠

  Confirmation statement overdue

  Due 2026-05-07.

• ⚠

  Material uncertainty over going concern

  The Directors believe that it remains appropriate to prepare the financial statements on a going concern basis. However, they also acknowledge that a material uncertainty exists that may cast significant doubt on the Group's ability to generate sufficient net revenues and resulting cash inflows and raise sufficient finance to meet its expected costs to discharge its liabilities in the normal course of business.

• ◆

  3 officer resignations in last 12 months

  Multiple officers have left the board recently — see the People section for who.

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +349.1%

  £3,100,968 → £13,926,122

• Cash

  -14.5%

  £7,714,182 → £6,596,201

• Net assets

  +63.7%

  £5,476,819 → £8,962,831

• Employees

  +13.3%

  15 → 17

• Operating profit

  +117.9%

  -£6,963,770 → £1,243,906

• Profit before tax

  +118.7%

  -£6,891,973 → £1,290,845

• Wages

  +3.4%

  £2,284,686 → £2,361,756

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.

1. FUTURA MEDICAL PLC 2001-07-11 → present
2. FUTURA (HOLDINGS) PLC 2001-04-25 → 2001-07-11

Accounting basis

IFRS

Reporting scope

Consolidated group

Auditor

Grant Thornton UK LLP

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“The Directors believe that it remains appropriate to prepare the financial statements on a going concern basis. However, they also acknowledge that a material uncertainty exists that may cast significant doubt on the Group's ability to generate sufficient net revenues and resulting cash inflows and raise sufficient finance to meet its expected costs to discharge its liabilities in the normal course of business.”

Group structure

1. FUTURA MEDICAL PLC · parent
   1. Futura Medical Developments Limited 100% · UK · research and commercialisation of consumer healthcare products
   2. Futura Consumer Healthcare Limited 100% · UK · commercial exploitation and branding of pharmaceutical drugs and medical devices developed by Futura Medical Developments Limited

Significant events

• “FY24 - A year of strategic achievement, significant revenue growth and maiden profit”
• “Initial launch of Eroxon in October 2024 in the US”
• “Eroxon now launched in over 15 countries across the Americas, Middle East and Europe”
• “New product development R&D pipeline progressing with positive results for Eroxon® Intense and WSD4000”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

14

last 12 months

Capital events

8

last 24 months

Officers appointed

1

last 12 months

Officers resigned

3

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.